Levosulpirida_[Inn-Spanish]

Category

Levosulpirida_[Inn-Spanish]




Useful info

Levosulpirida_[Inn-Spanish] Brand names, Levosulpirida_[Inn-Spanish] Analogs

Levosulpirida_[Inn-Spanish] Brand Names Mixture

  • No information avaliable

    • Levosulpirida_[Inn-Spanish] Chemical_Formula

    C15H23N3O4S

    Levosulpirida_[Inn-Spanish] RX_link

    No information avaliable

    Levosulpirida_[Inn-Spanish] fda sheet

    Levosulpirida_[Inn-Spanish] msds (material safety sheet)

    Levosulpirida_[Inn-Spanish] MSDS

    Levosulpirida_[Inn-Spanish] Synthesis Reference

    No information avaliable

    Levosulpirida_[Inn-Spanish] Molecular Weight

    341.427 g/mol

    Levosulpirida_[Inn-Spanish] Melting Point

    178 oC

    Levosulpirida_[Inn-Spanish] H2O Solubility

    2280 mg/L

    Levosulpirida_[Inn-Spanish] State

    Solid

    Levosulpirida_[Inn-Spanish] LogP

    1.337

    Levosulpirida_[Inn-Spanish] Dosage Forms

    Tablet

    Levosulpirida_[Inn-Spanish] Indication

    Sulpiride is indicated for the treatment of schizophrenia.

    Levosulpirida_[Inn-Spanish] Pharmacology

    Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.

    Levosulpirida_[Inn-Spanish] Absorption

    No information avaliable

    Levosulpirida_[Inn-Spanish] Toxicity

    No information avaliable

    Levosulpirida_[Inn-Spanish] Patient Information

    No information avaliable

    Levosulpirida_[Inn-Spanish] Organisms Affected

    Humans and other mammals